| IBB |
Search for genomic biomarkers for vitamin D response in patients with Covid-19 and IBD
| Inflammatory Bowel Disease, Vitamin D, SARS-CoV-2, RNA-seq, Extracellular vesicles |
| IBB |
The analysis of conservative and non-conservative amino acid mutations in SARS- CoV-2 variants provides insights into the early evolution of the virus in humans
| SARS-CoV-2, substitution matrices, amino-acid mutations |
| IBB |
Host-pathogen interactions in viral diseases: the case of SARS-CoV-2
| protein-protein interactions, respiratory disease; protein structure |
| IBB |
In vitro diagnostic turbidimetric methods for SARS-CoV-2
| Sars-CoV-2; Diagnostic test; Turbidimetry |
| IBB |
Monitoraggio domiciliare di parametri fisiopatologici di pazienti fragili
| Telemedicina, wearable medical devices, New Technologies for Covid-19 |
| IBBC |
Covid-19 and science communication: an opportunity to assess new formats in public engagement
| Covid19, science communication, digital transformation, public engagement |
| IBBC |
Pharmacological targeting CtBP1/BARS-controlled endocytic pathway to block SARS-CoV2 infection
| COVID-19, Membrane trafficking, Cellular Imaging |
| IBBC |
Regulation of gene expression of SARS-CoV2 Receptors
| SARS-CoV-2, ACE2 |
| IBFM |
In silico discovery of candidate drugs against COVID-19
| Bioinformatics, COVID-19, Drugs |
| IBFM |
Computational methods for biomedical data science
| biomedical data science, data integration, multi omics, AI, machine learning, cancer evolution, SARS-CoV-2, metabolic networks, precision medicine |
| IBIOM |
Yeast as a model to study the effect of SARS-CoV-2 non-structural proteins on cell stress response and interactions with cell components
| SARS-CoV-2, positive-strand RNA viruses, Saccharomyces cerevisiae, programmed cell death, cell membranes, replication organelles |
| IBIOM |
Comparative genomics provides an operational classification system and reveals early emergence and biased spatio-temporal distribution of SARS-CoV-2
| Comparative genomics of SARS-Cov2, evolution of viral types |
| IBIOM |
A comparative genomics approach for the study of the spatio-temporal distribution of SARS-CoV-2
| Comparative genomics; Genomic surveillance; Phylogeographic analyses; Bioinformatics |
| IBIOM |
A novel methodology for accurate detection and quantification of individual SARS-CoV-2 sub-genomic RNAs by droplet digital PCR (ddPCR) aimed at setting up an effective COVID-19 diagnostic strategy
| SARS-Cov2, ddPCR, sgRNA, quantification |
| IBIOM |
Building a digital space for Covid-19 research
| Galaxy, Laniakea, COVID-19 |
| IBIOM |
Bioinformatics approaches for COVID-19 genomics
| Bioinformatics; Comparative Genomics; Variant Prioritization; Big Data; COVID-19 |
| IBIOM |
(+)RNA virus replication-associated protein expression in Saccharomyces cerevisiae
| yeast, (+)RNA virus, SARS-CoV-2, cell membranes |
| IBPM |
Immune regulation and immuno-monitoring in human diseases: auto-immunity, cancer, and COVID-19
| immuno-monitoring; immuno-therapy; cellular senescence |
| IBPM |
A rare syndrome, as a tool to understand molecular pathways involved in SARS-CoV- 2 infection
| SARS-CoV-2, RNA binding proteins, RNA metabolism, rare disease |
| IEOS |
Identification of cytokine signature in first and second wave of COVID-19 pandemics
| cytokines, diagnostics, disease progression |
| IFC |
Exploiting RNA editing against the SARS-CoV-2: hacking the virus to identify molecular targets
| RNA Editing, Viral Restriction, Viral Evolution, Bioinformatic Analysis |
| IFC |
Design of an optimized path for data flow and management of patients characterized by clinical and radiological features compatible with COVID-19 (OPTIMISED)
| COVID-19, lung ultrasound, artificial intelligence |
| IFC |
Lung ultrasound to predict COVID-19 pneumonia: a multicenter descriptive study
| Lung ultrasound; COVID-19; light beam; interstitial pneumonia |
| IFC |
Evaluation of MULTIsystemic disease and immunological predisposition in patients with previous COVID19 (MULTICOVID)
| COVID-19, multiorgan disease, immune response, Magnetic Resonance Imaging |
| IFC |
LOST IN TOSCANA - Behavioral changes and psychological distress after the lockdown for Covid-19 in Tuscany, Lombardy and Italy: LOckdown and lifeSTyles IN Tuscany
| consumptions, lifestyles, psychological distress, lockdown |
| IFC |
TiAssisto Project
| Telemedicine, multipathology, multiparametric monitoring, fragility, Artificial Intelligence, Decision Support System, out of hospital ultrasound, medical imaging, biomedical computing, Covid-19 |
| IFC |
Development of composite polymeric matrices, containing metal nanoparticles and / or essential oils, with antiviral properties against VIRUS SARS-CoV-2 Sars-Cov-2 (STOP-VIRUS)
| polymeric matrices, coating, nanoparticles, essential oil, antiviral, sars-Cov-2 |
| IFC |
Research contract with Texcar SPA for the Development of Antiviral Textile Products
| Textile, Antiviral, Sars-Cov-2, copper |
| IFC |
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males
| SARS-CoVC-2; Toll-like Receptors; Autophagy; Chloroquine |
| IFT |
SARS-CoV-2 detection in clinical samples: Comparative analysis of different RNA extraction methods
| RNA extraction; SARS-CoV-2; rRT-PCR; Oro- nasopharyngeal swabs |
| IFT |
Set up of experimental models for the study of virus host interactions and discovery of novel host-targeted approaches against respiratory viruses
| respiratory viruses; influenza virus, coronaviruses; SARS-CoV-2; experimental models of infection; ACE2 modulators |
| IFT |
Esposizione alla nicotina, invecchiamento, machine learning e blockchain solution: un approccio multilivello basato su modelli in vitro e pazienti per costruire una road map del rischio per Covid-19
| Cell Proliferation; EMT; Mitochondrial Dysfunction; nAChR; Nicotine; SARS-CoV- 2 |
| IFT |
Therapeutic agents targeting SARS-CoV-2 S protein biogenesis and function
| Antivirals, coronavirus, drug repositioning, pseudovirus, stress response |
| IFT |
Comparazione della risposta anticorpale e sviluppo memoria immunitaria in pazienti COVID in età pediatrica e adulti
| COVID-19; SARS-CoV-2; antibodies; serological test |
| IFT |
Antiviral and Immunomodulatory Interferon-Beta in high-risk COVID-19 patients: a phase II clinical study
| Interferon-beta, Immunomodulation, clinical study, COVID-19 |
| IGB |
Genomics to fight the emerging COVID19 pandemic
| SARS-CoV-2, genomics, third generation sequencing |
| IGB |
The impact of COVID-19 on rare diseases: Incontinentia pigmenti (IP) as a model to improve the knowledgeon both COVID-19 and IP
| COVID-19, Incontinentia pigmenti, INF1 autoimmunity |
| IGB |
Pilot study at HLA locus: analysis of genetic profile to explain the susceptibility to SARS-CoV-2 infection in Southern Italy
| --- |
| IGB |
A Drug rEpurposing Approach to tackle pulMonary fibrosis in post Covid-19 patientS (DREAMS)
| --- |
| IGM |
The DDX family RNA helicases and SARS-COV-2: targeting host-virus interactions
| RNA helicase DDX3X, broad spectrum antivirals, hst pathogen-interactions |
| IN |
Disclosing Covid-19 gateways to the brain: viral trafficking based on in vitro models and patients’ samples
| COVID-19, viral trafficking, cellular imaging, olfactory system, visual system |
| IN |
Evaluation of Olfactory function in COVID-19
| --- |
| IN |
Produzione di librerie di anticorpi neutralizzanti ad uso terapeutico da pazienti Covid- 19 (PAN-ANTI COVID 19)
| --- |
| IN |
Adaptive performance of the Tuscany Stroke Network to the COVID 19 outbreak: a retrospective study
| --- |
| IN |
NEURODEVELOPMENTAL EFFECTS ON CHILDREN BORN FROM COVID-19-AFFECTED PREGNANT WOMEN
| --- |
| IRGB |
Role of genetic variants at ACE2 and TMPRSS2 genes involved in SARS-CoV-2 infection in human phenotypes
| ACE2, TMPRSS2, genetics, COVID19 |
| IRGB |
Idiopatic Pulmonary Fibrosis genomic profile and its molecular correlation with interstitial fibrosis induced by SARS-CoV2 and Pulmonary Adenocarcinoma
| Idiopathic Pulmonary Fibrosis (IPF), Lung Adenocarcinoma (LAC), Covid-19 Pulmonary Fibrosis (PF) |
| IRIB |
TOLEPATI' for COVID-19: Technological innovation at the service of the patient care
| Sars-Cov-2, telemedicine, innovative digital platform |
| ITB |
CoV-ncRNASig: a bioinformatic tool for the prediction of smallRNA interference between Coronaviruses and humans
| non-codingRNA, RNA-interference, host-virus-interaction |
| ITB |
EPICOVID19 - National Epidemiological Survey on COVID-19
| Web-based survey; COVID-19; Epidemiological study |